a developer of novel oral antiviral therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, CMRX has been loosely correlated with FGEN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CMRX jumps, then FGEN could also see price increases.
Ticker / NAME | Correlation To CMRX | 1D Price Change % | ||
---|---|---|---|---|
CMRX | 100% | -3.32% | ||
FGEN - CMRX | 35% Loosely correlated | -2.57% | ||
MRSN - CMRX | 34% Loosely correlated | +3.04% | ||
ENTA - CMRX | 33% Poorly correlated | +2.22% | ||
AXON - CMRX | 32% Poorly correlated | +5.26% | ||
VCYT - CMRX | 32% Poorly correlated | -1.04% | ||
More |